Director, Pharmacokinetics, Modeling and Simulation Astellas Pharma, Illinois
Clinical pharmacology is changing. Twenty years ago companies were small molecule focused; today, small molecules represent a small proportion of many companies portfolios. These new modalities, like CAR-T and gene therapy, challenge the concept of what is clinical pharmacology and the roles and responsibilities of a clinical pharmacologist. This talk will discuss these changes, provide a glimpse into what the future might hold, and how a clinical pharmacologist can remain relevant to drug development.
Upon completion, participants will understand the changing face of clinical pharmacology and how we got to this point today.
Upon completion, participants will recognize the challenges facing current and future clinical pharmacologists.
Upon completion, participants will understand the skill set needed to remain relevant in drug development in the future.